20250228953. Intracellular Targe (Entrada Therapeutics, .)
Appearance
INTRACELLULAR TARGETING OF OLIGONUCLEOTIDES
Abstract: compounds are provided include a cell penetrating peptide, a therapeutic oligonucleotide, and a carbohydrate targeting moiety. the compounds may also include an exocyclic peptide. the compounds may be targeted to liver cells. the therapeutic oligonucleotide may be an oligonucleotide for treating a disease or disorder associated with a liver cell.
Inventor(s): Ziqing Qian, Mahboubeh Kheirabadi, Matthew Streeter
CPC Classification: A61K47/64 (Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent (peptidic linkers ))
Search for rejections for patent application number 20250228953